Head-to-Head

Halozyme Therapeutics, Inc. vs. X4 Pharmaceuticals, Inc. Common Stock

HALO

Halozyme Therapeutics, Inc.

$100.27 -0.40%

VS XFOR

X4 Pharmaceuticals, Inc. Common Stock

$2.83 -9.29%

Halozyme Therapeutics, Inc. and X4 Pharmaceuticals, Inc. Common Stock are evenly matched on the factors we track — the better pick depends on what you're optimizing for.

Size & Scale

HALOXFOR
Market Cap $11.43 billion $318.59 million

HALO leads on 1 of 1 size & scale factors.

Risk & Sentiment

HALOXFOR
Short Interest 9.75% 0.08%

XFOR leads on 1 of 1 risk & sentiment factors.

Dig deeper: HALO overview, HALO financials, XFOR overview, XFOR financials.

Comparisons use delayed, cached fundamental data and cover only the factors shown. For informational purposes only — not investment advice.